Get the latest Science News and Discoveries

Role of fibrinogen-like protein 1 in tumor recurrence following hepatectomy - EurekAlert


Hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality globally, exhibits a dismal five-year survival rate of only 18%. Major contributing factors to HCC include viral hepatitis infections and nonalcoholic fatty liver disease. Despite advancements in chemotherapy and radiotherapy, which have shown efficacy in controlling HCC, these treatments are often accompanied by severe side effects. As a result, surgical interventions such as liver transplantation and partial hepatectomy (PH) remain the primary therapeutic strategies, particularly in the early stages of HCC. Among these, PH is crucial due to the scarcity of suitable organs for transplantation. However, a significant drawback of PH is the high rate of tumor recurrence, with about 70% of patients experiencing recurrence within five years.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of role

role

Photo of EurekAlert

EurekAlert

Photo of tumor recurrence

tumor recurrence

Related news:

News photo

New therapy strengthens the immune system's counterattack on skin cancer - EurekAlert

News photo

Protein nanocages pave the way for effective mRNA therapeutics - EurekAlert

News photo

New lab test to detect persistent HIV strains in Africa may aid search for cure - EurekAlert